-
Article
Open AccessSphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α
Non-alcoholic steatohepatitis (NASH) is a severe type of the non-alcoholic fatty liver disease (NAFLD). NASH is a growing global health concern due to its increasing morbidity, lack of well-defined biomarkers ...
-
Article
The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice
Polycystic ovary syndrome (PCOS), an endocrine disorder afflicting 6–20% of women of reproductive age globally, has been linked to alterations in the gut microbiome. We previously showed that in PCOS, elevatio...
-
Article
Comprehensive insights: unraveling the mechanisms of gut commensals in glucose metabolism regulation
-
Article
Open AccessParabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a
Gut microbiota plays a key role in insulin resistance (IR). Here we perform a case-control study of Chinese adults (ChiCTR2200065715) and identify that Parabacteroides distasonis is inversely correlated with IR. ...
-
Article
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Tobacco smoking is positively correlated with non-alcoholic fatty liver disease (NAFLD)1–5, but the underlying mechanism for this association is unclear. Here we report that nicotine accumulates in the intestine ...
-
Article
Hypoglycemic mechanism of polysaccharide from Cyclocarya paliurus leaves in type 2 diabetic rats by gut microbiota and host metabolism alteration
Diabetes mellitus is a serious threat to human health. Cyclocarya paliurus (Batal.) Il**skaja (C.paliurus) is one of the traditional herbal medicine and food in China for treating type 2 diabetes, and the C. pal...